DOI: 10.1515/mr-2024-0007
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Zara Siu Wa Chui
Yaqian Xue
Aimin Xu
Keywords:metabolic hormonesmetabolic dysfunction-associated steatohepatitis(MASH)liver fibrosisbiophar-maceutical developmentclinical trials
Publication Date:2024-04-28
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:11( 158-168 )
